Crossmark

Targeted disease-specific therapy for patients with hereditary transthyretin amyloidosis and cardiac involvement after orthotopic liver transplantation. Consensus from the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology and National Reference Centers for Familial Amyloidosis

Crossref DOI link: https://doi.org/10.1016/j.repc.2024.11.008

Published Print: 2025-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Aguiar Rosa, Sílvia

Ferreira, Catarina

Conceição, Isabel

Coelho, Teresa

Marques, Nuno

Azevedo, Olga
License Information

Text and Data Mining valid from 2025-02-01

Text and Data Mining valid from 2025-02-01

Version of Record valid from 2025-01-11
More Information

This article is maintained by: Elsevier

Article Title: Targeted disease-specific therapy for patients with hereditary transthyretin amyloidosis and cardiac involvement after orthotopic liver transplantation. Consensus from the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology and National Reference Centers for Familial Amyloidosis

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2024.11.008

Content Type: article

Copyright: © 2025 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below